LumaBridge Announces Growth Equity Investment From Summit Partners
SAN ANTONIO & BOSTON–(BUSINESS WIRE)–LumaBridge (formerly known as Cancer Insight), an oncology-focused clinical research organization (CRO), today announced a majority growth investment from global investor Summit Partners. The funding will help LumaBridge continue to build on its work offering best-in-class clinical trial solutions to support emerging biopharma companies that are working to develop life-changing immuno-oncology … [Read more…]